Literature DB >> 28005572

Polyreactive natural antibodies in transplantation.

Emmanuel Zorn1, Sarah B See.   

Abstract

PURPOSE OF REVIEW: Antibody-mediated rejection (ABMR), especially in its chronic manifestation, is increasingly recognized as a leading cause of late graft loss following solid organ transplantation. In recent years, autoantibodies have emerged as a significant component of the humoral response to allografts alongside anti-human leukocyte antigen antibodies. These include polyreactive antibodies also known as natural antibodies (Nabs) secreted by innate B cells. A hallmark of Nabs is their capacity to bind altered self such as oxidized lipids on apoptotic cells. This review provides an overview of these overlooked antibodies and their implication in the pathophysiology of ABMR. RECENT
FINDINGS: New evidence reported in the past few years support a contribution of immunoglobulin (Ig) G Nabs to ABMR. Serum IgG Nabs levels are significantly higher in patients with ABMR compared with control kidney transplant recipients with stable graft function. Pretransplant IgG Nabs are also associated with ABMR and late graft loss. IgG Nabs are almost exclusively of the IgG1 and IgG3 subclasses and have the capacity to activate complement.
SUMMARY: In conclusion, Nabs are important elements in host immune responses to solid organ grafts. The recent description of their implication in ABMR and late kidney graft loss warrants further investigation into their pathogenic potential.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28005572      PMCID: PMC8667280          DOI: 10.1097/MOT.0000000000000376

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  90 in total

Review 1.  The role of complement in inflammation and adaptive immunity.

Authors:  R Barrington; M Zhang; M Fischer; M C Carroll
Journal:  Immunol Rev       Date:  2001-04       Impact factor: 12.988

2.  Induction of natural autoantibody activity following treatment of human immunoglobulin with dissociating agents.

Authors:  J P Bouvet; D Stahl; S Rose; C P Quan; M D Kazatchkine; S V Kaveri
Journal:  J Autoimmun       Date:  2001-03       Impact factor: 7.094

3.  Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation.

Authors:  Maryvonne Hourmant; Anne Cesbron-Gautier; Paul I Terasaki; Kazuo Mizutani; Anne Moreau; Aurélie Meurette; Jacques Dantal; Magali Giral; Gilles Blancho; Diego Cantarovich; Georges Karam; Gilles Follea; Jean-Paul Soulillou; Jean-Denis Bignon
Journal:  J Am Soc Nephrol       Date:  2005-07-13       Impact factor: 10.121

4.  Pathogenic natural antibodies propagate cerebral injury following ischemic stroke in mice.

Authors:  Andrew Elvington; Carl Atkinson; Liudmila Kulik; Hong Zhu; Jin Yu; Mark S Kindy; V Michael Holers; Stephen Tomlinson
Journal:  J Immunol       Date:  2011-12-23       Impact factor: 5.422

5.  Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction.

Authors:  Michael S Haas; Elisabeth M Alicot; Franziska Schuerpf; Isaac Chiu; Jinan Li; Francis D Moore; Michael C Carroll
Journal:  Cardiovasc Res       Date:  2010-05-11       Impact factor: 10.787

6.  Anti-phospholipid antibodies restore mesenteric ischemia/reperfusion-induced injury in complement receptor 2/complement receptor 1-deficient mice.

Authors:  Sherry D Fleming; Ryan P Egan; Chunyan Chai; Guillermina Girardi; V Michael Holers; Jane Salmon; Marc Monestier; George C Tsokos
Journal:  J Immunol       Date:  2004-12-01       Impact factor: 5.422

7.  Early inhibition of caspase-3 activity lessens the development of graft coronary artery disease.

Authors:  Leora B Balsam; G Kimia Mokhtari; Sophie Jones; Shannon Peterson; E Grant Hoyt; Theo Kofidis; Masashi Tanaka; David T Cooke; Robert C Robbins
Journal:  J Heart Lung Transplant       Date:  2005-07       Impact factor: 10.247

8.  Increased negative impact of donor HLA-specific together with non-HLA-specific antibodies on graft outcome.

Authors:  Nancy L Reinsmoen; Chih-Hung Lai; James Mirocha; Kai Cao; Geraldine Ong; Mehrnoush Naim; Qi Wang; Mark Haas; Matthew Rafiei; Lawrence Czer; Jignesh Patel; Jon Kobashigawa
Journal:  Transplantation       Date:  2014-03-15       Impact factor: 4.939

9.  Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen.

Authors:  Stephanie Kruetzmann; M Manuela Rosado; Holger Weber; Ulrich Germing; Olivier Tournilhac; Hans-Hartmut Peter; Reinhard Berner; Anke Peters; Thomas Boehm; Alessandro Plebani; Isabella Quinti; Rita Carsetti
Journal:  J Exp Med       Date:  2003-04-07       Impact factor: 14.307

10.  Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition.

Authors:  Khaled Amara; Johanna Steen; Fiona Murray; Henner Morbach; Blanca M Fernandez-Rodriguez; Vijay Joshua; Marianne Engström; Omri Snir; Lena Israelsson; Anca I Catrina; Hedda Wardemann; Davide Corti; Eric Meffre; Lars Klareskog; Vivianne Malmström
Journal:  J Exp Med       Date:  2013-02-25       Impact factor: 14.307

View more
  8 in total

Review 1.  Heterogeneity of memory B cells.

Authors:  Anita S Chong; M Javeed Ansari
Journal:  Am J Transplant       Date:  2018-02-13       Impact factor: 8.086

2.  B cell clonal expansion within immune infiltrates in human cardiac allograft vasculopathy.

Authors:  Carolina Moore; Baoshan Gao; Krishna M Roskin; Elena-Rodica M Vasilescu; Linda Addonizio; Michael M Givertz; Joren C Madsen; Emmanuel Zorn
Journal:  Am J Transplant       Date:  2019-12-27       Impact factor: 8.086

Review 3.  Evolving Approaches in the Identification of Allograft-Reactive T and B Cells in Mice and Humans.

Authors:  James S Young; Christine McIntosh; Maria-Luisa Alegre; Anita S Chong
Journal:  Transplantation       Date:  2017-11       Impact factor: 4.939

Review 4.  New Answers to Old Conundrums: What Antibodies, Exosomes and Inflammasomes Bring to the Conversation. Canadian National Transplant Research Program International Summit Report.

Authors:  Mélanie Dieudé; Lori J West; Daniel A Muruve; Lakshman Gunaratnam; Thalachallour Mohanakumar; Emmanuel Zorn; Christopher W Cairo; Darren H Freed; Kirk R Schultz; Robert L Fairchild; Marie-Josée Hébert
Journal:  Transplantation       Date:  2018-02       Impact factor: 4.939

5.  Increased Autoantibodies Against Ro/SS-A, CENP-B, and La/SS-B in Patients With Kidney Allograft Antibody-mediated Rejection.

Authors:  Sergi Clotet-Freixas; Max Kotlyar; Caitriona M McEvoy; Chiara Pastrello; Sonia Rodríguez-Ramírez; Sofia Farkona; Heloise Cardinal; Mélanie Dieudé; Marie-Josée Hébert; Yanhong Li; Olusegun Famure; Peixuen Chen; S Joseph Kim; Emilie Chan; Igor Jurisica; Rohan John; Andrzej Chruscinski; Ana Konvalinka
Journal:  Transplant Direct       Date:  2021-09-20

6.  Natural Antibodies and Alloreactive T Cells Long after Kidney Transplantation.

Authors:  Nicole M van Besouw; Aleixandra Mendoza Rojas; Sarah B See; Ronella de Kuiper; Marjolein Dieterich; Dave L Roelen; Marian C Clahsen-van Groningen; Dennis A Hesselink; Emmanuel Zorn; Carla C Baan
Journal:  J Transplant       Date:  2021-09-30

Review 7.  Effector B cells in cardiac allograft vasculopathy.

Authors:  Emmanuel Zorn
Journal:  Curr Opin Organ Transplant       Date:  2019-02       Impact factor: 2.640

8.  Relationship between natural and infection-induced antibodies in systemic autoimmune diseases (SAD): SLE, SSc and RA.

Authors:  K Böröcz; D Simon; S Erdő-Bonyár; K T Kovács; É Tuba; L Czirják; P Németh; T Berki
Journal:  Clin Exp Immunol       Date:  2020-10-13       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.